IP Library Granted Patent US 11,022,609
Granted Patent B2
US 11,022,609 · App. 15/034,084 · Granted Jun 1, 2021

Method for determining interaction kinetics with rapid dissociation

Inventor: Olof Karlsson (Uppsala, SE)
Assignee: GE HEALTHCARE BIO-SCIENCES AB
G01N33/54373G01N21/272G01N21/553G01N21/554
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,022,609
App. No.
15/034,084
Granted
Jun 1, 2021
Kind
B2
Abstract

The invention relates to a method for determining interaction kinetics for an analyte. The method comprises first contacting a solution containing the analyte with immobilized ligand, or analogue thereof, immobilized on an optical sensor surface; monitoring the binding of the analyte to the immobilized ligand or analogue, wherein the binding is measured as a resulting change in a property of the surface; and automatically determining the interaction kinetics, which determining step includes first defining parts of the dissociation phase that contains kinetic information for fitting. The invention further relates to an analytical system for studying molecular interactions, which system is capable of performing the novel method, as well as a computer program product for performing the steps of the method.

Claims (33)

1. A method for controlling a biosensor system to determine interaction kinetics for an analyte, the method comprising:

a) monitoring binding of said analyte, said analyte contained in a solution, to an immobilized ligand or analogue thereof, the immobilized ligand or analogue thereof immobilized on an optical sensor surface, wherein the binding is measured as a resulting change in a property of said surface indicative of at least a dissociation phase between the ligand or analogue and the analyte;

b) automatically determining said interaction kinetics, wherein determining further includes:

defining a first part of the dissociation phase that includes kinetic information;

excluding a second part of the dissociation phase as including non-kinetic information; and

fitting an interaction model to the first part of the dissociation phase to automatically determine said interaction kinetics with respect to the ligand and the analyte; and

c) triggering control software to stop data generation when the dissociation phase is complete.

2. The method according to claim 1 , wherein said ligand, or analogue thereto, is immobilized to a series of surfaces.

3. The method according to claim 1 , wherein said optical sensor surface is part of a detector based upon evanescent wave sensing.

4. The method according to claim 3 , wherein said evanescent wave sensing is based on surface plasmon resonance.

5. The method according to claim 1 , wherein defining parts of the dissociation phase that contains kinetic information for fitting is done by excluding response data less than:

R=Y high /x,

wherein R is the response in RU below which dissociation phase data is excluded from fitting,

Y high is the highest response relative to baseline during the dissociation phase on each curve, and

x is an arbitrary number set by user or coded in program software.

6. The method according to claim 5 , wherein x is 20.

7. The method according to claim 1 , wherein defining parts of the dissociation phase that contains kinetic information for fitting is done by excluding response data less than R=0 (baseline), wherein R is the response in RU below which dissociation phase data is excluded from fitting.

8. The method according to claim 1 , wherein defining parts of the dissociation phase that contains kinetic information for fitting is done by excluding response data less than R=x (x is a number set by user or coded in a program), wherein R is the response in RU below which dissociation phase data is excluded from fitting.

9. The method according to claim 1 , wherein said determining further includes adjusting dissociation phase data for drifts, disturbances or single deviating curves for fitting.

10. An analytical system for studying molecular interactions, which system comprises computer processing means including program code means for performing a method for controlling a biosensor system to determine interaction kinetics for an analyte, the method including:

monitoring binding of an analyte in a solution with an immobilized ligand or analogue on an optical sensor surface, wherein the binding is measured as a resulting change in a property of said surface indicative of at least a dissociation phase between the ligand or analogue and the analyte; and

automatically determining said interaction kinetics, wherein determining further includes:

defining a first part of the dissociation phase that includes kinetic information;

excluding a second part of the dissociation phase as including non-kinetic information;

fitting an interaction model to the first part of the dissociation phase to determine said interaction kinetics with respect to the ligand and the analyte; and

triggering control software to stop data generation when the dissociation phase is complete.

11. A computer program product comprising program code means stored on a computer readable medium to implement a method for controlling a biosensor system to determine interaction kinetics for an analyte, the method including:

monitoring binding of an analyte in a solution with an immobilized ligand or analogue on an optical sensor surface, wherein the binding is measured as a resulting change in a property of said surface indicative of at least a dissociation phase between the ligand or analogue and the analyte; and

automatically determining said interaction kinetics, wherein determining further includes:

defining a first part of the dissociation phase that includes kinetic information;

excluding a second part of the dissociation phase as including non-kinetic information;

fitting an interaction model to the first part of the dissociation phase to determine said interaction kinetics with respect to the ligand and the analyte; and

triggering control software to stop data generation when the dissociation phase is complete.

Assignments (2)
CHANGE OF NAME Recorded Apr 20, 2022
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 059707/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2016
From: KARLSSON, OLOF
To: GE HEATLHCARE BIO-SCIENCES AB
Reel/Frame 038479/0833 →
Continuity (2)
Provisional Application 61905962 · Nov 19, 2013
Related Publication 20160282342A1 · Sep 29, 2016